How generative AI could transform the $30 billion biotech industry, speeding up everything from drug discovery to DNA sequencing

• The explosive growth of generative AI has been embraced by biotech founders.
• Biotech startups are using generative AI for everything from protein creation to DNA sequencing.
• “This is going to explode after an inflection point,” Lux Capital’s Tess van Stekelenburg said.

ChatGPT has kickstarted a frenzy around generative AI.